Nanophase reports record Q1 revenue $9.9M, net income $0.9M vs loss, BASF litigation resolved

SOLESENCE, INC.

2024-Q1 EPS reported $0.02 revenue$9,868,000

Q1 revenue $9.9M (+4% YoY); net income $0.9M vs net loss of $1.2M in Q1 2023.
Gross margin improved to 36% from 23% YoY; Solésence product revenue contributed $8.0M.
BASF litigation amicably resolved; company expects breakout year with $40M+ in shipped/open orders.
Three consecutive profitable months (Jan-Mar 2024); margin expansion due to improved product mix.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.92

SOLESENCE, INC. reported the first quarter ended March 31, 2024 results: revenue $9.9 million, net income $0.9 million.

Period: the first quarter ended March 31, 2024
Revenue: $9.9 million
Net income: $0.9 million
Result: reported results

Exact text from the filing

herein by reference. --- EX-99.1 (PRESS RELEASE) --- EX-99.1 2 exh_991.htm PRESS RELEASE EdgarFiling EXHIBIT 99.1 Nanophase Reports Record First Quarter Results — Delivered $9.9 Million in Q1 Revenue — $0.9 Million in Profit — BASF Litigation Resolved ROMEOVILLE, Ill., April 23, 2024 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX), a leader

View on SEC.gov

493 earnings releases filed in the last 30 days. Browse all earnings releases →

SOLESENCE, INC. filing history →

Source: SEC EDGAR

accession 0001171843-24-002152

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.